Tuberc Respir Dis > Accepted Articles
DOI: https://doi.org/10.4046/trd.2021.0135    [Accepted]
Published online September 13, 2021.
Treatment Outcomes of Patients with Multidrug-resistant Tuberculosis: Concern to Bedaquiline - Authors’ reply
Yewon Kang1, Jeongha Mok2,3,4
1Department of Internal Medicine, Dongkang Medical Center, Ulsan, Republic of Korea
2Department of Internal Medicine, Pusan National University Hospital, Busan, Republic of Korea
3Pusan National University School of Medicine, Busan, Republic of Korea
4Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
Correspondence:  Jeongha Mok, Tel: 82-51-240-7889, Fax: 82-51-254-3127, 
Email: mokgamokga@gmail.com
Received: 5 September 2021   • Revised: 10 September 2021   • Accepted: 12 September 2021


ABOUT
ARTICLE & TOPICS
Article category

Browse all articles >

Topics

Browse all articles >

BROWSE ARTICLES
FOR CONTRIBUTORS
Editorial Office
101-605, 58, Banpo-daero, Seocho-gu (Seocho-dong, Seocho Art-Xi), Seoul 06652, Korea
Tel: +82-2-575-3825, +82-2-576-5347    Fax: +82-2-572-6683    E-mail: katrdsubmit@lungkorea.org                

Copyright © 2021 by The Korean Academy of Tuberculosis and Respiratory Diseases. All rights reserved.

Developed in M2PI

Close layer
prev next